Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Haupt Pharma Wülfing is a prominent contract development and manufacturing organization (CDMO) based in Gronau, Germany, and operates as a key site within the Aenova Group. The facility specializes in the production of solid and liquid dosage forms, including tablets, film-coated tablets, hard gelatin capsules, and various oral liquids. It offers a full suite of services from early-stage pharmaceutical development and clinical trial material manufacturing to large-scale commercial production and specialized packaging. The site is recognized for its high quality standards and its ability to handle complex manufacturing requirements for global pharmaceutical partners. With a history dating back to the 19th century as Wülfing Pharma, it combines long-standing expertise with modern GMP-compliant infrastructure.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Haupt Pharma Wülfing.